본문

  1. Home
4 Results:AA:LINDSAY R PP:ELSEVIER INC 0.156 sec.
RSS 
Multilingual
 Búsqueda Avanzada
 Nueva llegada Buscar
Selected Print Select Export to Excel
1
A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density
A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density
Saag, K., | Elsevier Inc | 2007 ,
2
Beyond clinical trials: The importance of large databases in evaluating differences in the effectiveness of bisphosphonate therapy in postmenopausal osteoporosis
Beyond clinical trials: The importance of large databases in evaluating differences in the effectiveness of bisphosphonate therapy in postmenopausal osteoporosis
Lindsay, R, | Elsevier Inc | 2007 ,
3
Are all bisphosphonates the same?
Are all bisphosphonates the same?
Lindsay, R., | Elsevier Inc | 2007 ,
4
Effects of cyclic vs. daily treatment with human parathyroid hormone (1–34) on murine bone structure and cellular activity
Effects of cyclic vs. daily treatment with human parathyroid hormone (1–34) on murine bone structure and cellular activity
Iida-Klein, A., | Elsevier Inc | 2007 ,
처음1마지막